InvestorsHub Logo
Followers 172
Posts 10472
Boards Moderated 6
Alias Born 09/17/2000

Re: None

Thursday, 11/04/2010 12:09:51 PM

Thursday, November 04, 2010 12:09:51 PM

Post# of 580
Run-- Stellar--Run! $3 soon?

About Stellar Pharmaceuticals Inc.



Stellar has developed and is marketing direct in Canada and in countries around the world through out-license agreements two products based on its core polysaccharide technology: NeoVisc®, for the treatment of osteoarthritis; and Uracyst®, its patented technology for treatment of interstitial cystitis/painful bladder syndrome, an inflammatory disease of the urinary bladder wall. Stellar also has in-licensing agreement for the distribution and sale of NMP22® BladderChek®, a proteomics-based diagnostic test for the diagnosis and monitoring of bladder cancer. For more information, please visit the company's website at www.stellarpharma.com





futr


My opinions are my own and and DD I post should be confirmed as unbiased

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.